LMNA (Lamin A/C) Gene Mutation Analysis

LMNA (Lamin A/C) Gene Mutation Analysis
Emery-Dreifuss Muscular Dystrophy (Autosomal)
Limb-Girdle Muscular Dystrophy (Type 1B)
Dilated Cardiomyopathy
Charcot-Marie-Tooth Neuropathy Type 2
Familial Partial Lipodystrophy, Dunnigan Type
Hutchinson-Gilford Progeria Syndrome
Atypical Werner Syndrome
Mandibuloacral Dysplasia

Germline mutations in the LMNA gene encoding lamins A and C have been found in patients with Emery- Dreifuss muscular dystrophy (autosomal dominant, autosomal recessive, and sporadic forms of the disease 1~4 in limb-girdle muscular dystrophy (Type 1B)5, in Charcot-Marie-Tooth disorder type 26, and in Dunnigan type familial partial lipodystrophy7. Mutations in the LMNA gene have also been detected in patients with Hutchinson-Gilford progeria syndrome 8, 9, atypical Werner syndrome10, and mandibuloacral dysplasia. Mutations in this gene also have been reported to cause familial dilated cardiomyopathy, a genetically heterogeneous disease caused by perhaps as many as eleven different genes, only a few of which have been identified 11, 12. Identification of lamin A/C gene mutations in patients with any of these diseases may permit identification of carriers as well as individuals who are at high risk for dilated cardiomyopathy in these families.

To open a printable assay summary in a new window, click the link below.

Lamin A/C (LMNA) Gene Mutation Analysis Assay Summary
(in portable document format (pdf) which requires Adobe® Acrobat® Reader™ to view or print; download latest version free)

Please submit the Test Request Form (TRF).

References
1. LeBonne, G. et al. (1999) Nat. Genet. 21: 285-288.
2. Genschel, J. and Schmidt, H.H.-J. (2000) Hum. Mut. 16: 451-459.
3. DiBarletta, M.R. et al. (2000) Am.J.Hum.Genet. 66: 1407-1412.
4. Brown, C.A. et al. (2001) Am. J. Med. Genet. 102: 359-367.
5. Muchir, A. et al. (2000). Hum. Molec. Genet. 9: 1453-1459.
6. De Sandre-Giovannoli, A. et al. (2002) Am. J. Hum. Genet. 70:726-736.
7. Shackleton, S. et al. (2000) Nat. Genet. 24:153-156.
8. Eriksson, M. et al. (2003) Nature 423:293-298.
9.Goldman, R.D. et al. (2004) Proc. Nat. Acad. Sci. USA 101:8963-8968.
10. Csoka, A.B. et al. (2004) J. Med. Genet. 41:304-308.
11. Fatkin, D. et al. (1999). N. Engl. J. Med. 341: 1715-1724.
12. Brodsky, G.L. et al. (2000). Circulation 101 473-476.

Back to the List of Services

Connective Tissue Disorders

Muscular Dystrophies/Cardiomyopathies

NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.